Daily Archives: February 23, 2012

More birth defects lawsuits filed against Zoloft makers

February 23, 2012 Pharmaceutical

More lawsuits have been filed against drug maker Pfizer by women who claim that the company hid information that showed using the antidepressant Zoloft during pregnancy could cause birth defects. The class action lawsuit was filed in St. Louis Circuit ... Read More

FDA panel recommends approval of controversial diet drug Qnexa

February 23, 2012 Pharmaceutical

A new diet drug may soon be available for people battling the bulge, but it may come at a price. This week, a Food and Drug Administration (FDA) advisory panel reviewed clinical data on the weight loss drug Qnexa and ... Read More

BP, Anadarko will pay civil penalties for oil spill, judge rules

February 23, 2012 Environmental

BP and minority partner Anadarko Petroleum Corp. will have to pay civil penalties for violations of the Clean Water Act that led to the massive Gulf of Mexico oil spill, U.S. District Judge Carl Barbier, who is presiding over BP ... Read More

Memo reveals DePuy knew its hip implants were defective but continued to sell them

February 23, 2012 Pharmaceutical

Top executives for Johnson & Johnson subsidiary DePuy Orthopaedics had evidence that one of the company’s all-metal artificial hip devices was failing prematurely in patients a year before the device was recalled, but withheld this information and continued to market ... Read More

Consumer group lobbies for stricter oversight of medical devices

February 23, 2012 Pharmaceutical

Consumers Union (CU) is joining the fight to urge lawmakers to require stricter oversight of medical devices, especially since it says the current practice puts consumers, especially senior citizens, at risk for ongoing complications. CU is a nonprofit consumer watchdog ... Read More

Gulf states are one step closer to acquiring BP oil-spill fines

February 23, 2012 Environmental

Legislators from the Gulf States are one step closer to making sure billions of dollars in oil-spill fine money collected from BP’s violations of the Clean Water Act will go to the Gulf Coast states rather than into the federal ... Read More

FDA considers approval of diet drug despite birth defects, heart risks

February 23, 2012 Pharmaceutical

Drug maker Vivus Inc., is hoping to win Food and Drug Administration (FDA) approval for its diet drug Qnexa this week after a rejection in 2010 due to serious health concerns. Experts say the chances of the weight loss drug ... Read More